Venture Capital Investors
TruVenturo
VC investing group TruVenturo backs promising tech companies.
Venture Investor Overview
Venture Investor
TruVenturo
Investor Type
Venture Capital
Industry Focus
Healthcare IT
Life Sciences
Contact Information
Title
Chief Executive Officer
Mailing Address
Große Reichenstraße 27
Hamburg, 20457
Germany
Background Information
Overview
TruVenturo is investing since 2009 and has invested through various industries. We learned timing is one of the most important parts of venture investing. We believe venture capital will make the best returns if you invest in the big future markets. Therefore we are strong believers in Tech (managed by Norbert Beck), Brain Computer Interface (managed by Florian Haupt) and pharma to prevent age related disease and prolong healthy human lifespan managed by Nils Regge with the investment vehicle Apollo.vc.
Last Transaction
5/26/2025
Transaction History
Our records indicate that TruVenturo invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.
5/26/2025
Undisclosed
$5,700,000
1/11/2024
Series A
$12,000,000
2/21/2022
Undisclosed
$45,000,000
Investor Contacts
Managing Partner
Norbert Beck
Chief Executive Officer
Nils Regge
Partner
Felix Scheder-Bieschin
Funds
No fund closings have been recorded for this company.
Portfolio Companies
TruVenturo has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.
San Francisco, CA 94122 USA
Browse more venture capital investors:
TrustLabs | Truxton Trust
Share this article
About Our Venture Capital Investor Database
This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs